Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02131727 · ClinicalTrials.gov registry record · NA
Hand Hygiene Randomized Cluster Intervention to Reduce Infections
A NA study of Respiratory Tract Infections and Gastrointestinal Infections, sponsored by Kent State University.
- Completed
- Registry status
- NA
- Development phase
- 324
- Enrollment target
- 1
- Study location
NCT02131727: Completed NA study of Respiratory Tract Infections and Gastrointestinal Infections, sponsored by Kent State University.
NCT02131727 is a NA study of Respiratory Tract Infections and Gastrointestinal Infections that has completed, run by Kent State University. The registered enrollment target is 324 participants, below the 2,753-participant average among 15 other Respiratory Tract Infections trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02131727, a NA study of Respiratory Tract Infections and Gastrointestinal Infections, has completed, sponsored by Kent State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 324 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if a simple intervention to improve hand hygiene, consisting of a 3-4 minute training video, on-site posters, and hand hygiene supplies, can reduce respiratory and GI illness among employees.
Primary Outcome
Monthly surveys elicited information among employees in both the intervention and the control group about self-reported usual hand hygiene practices, symptoms of respiratory and GI infections and missed work days due to these symptoms during the prior 30 days. After the close of the study, statistical analysis was conducted to determine relative reductions in the intervention group compared to the control group regarding: self-reported infections and work days missed due to such infections.
Conditions Studied
Interventions
- BEHAVIORAL Hand Hygiene Improvement Intervention
- BEHAVIORAL Ask Me 3
Study Locations (1)
Ohio
- Kent State University - Kent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 324 participants |
| Start Date | 2013-02 |
| Est. Completion | 2013-06 |
| Phase | NA |
What the finished NCT02131727 record still lists
NCT02131727 is an interventional study that assigns participants to a tested intervention. The registered 324 participants enrollment target is mid-sized for trials with a published cap, below the 2,753-participant average among 15 other Respiratory Tract Infections trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with Respiratory Tract Infections appearing as the primary indexed condition, and to 2 interventions - of which Hand Hygiene Improvement Intervention is the first listed.
NCT02131727 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02131727 about?
NCT02131727 is a clinical study titled "Hand Hygiene Randomized Cluster Intervention to Reduce Infections". The purpose of this study is to determine if a simple intervention to improve hand hygiene, consisting of a 3-4 minute training video, on-site posters, and hand hygiene supplies, can reduce respiratory and GI illness among employees.
What is the current status of trial NCT02131727?
This trial is currently completed. It is a NA study. The enrollment target is 324 participants. The study started on 2013-02. Estimated completion is 2013-06.
What conditions does trial NCT02131727 study?
This clinical trial studies the following conditions: Respiratory Tract Infections, Gastrointestinal Infections.
What interventions are being tested in trial NCT02131727?
The interventions under investigation include: Hand Hygiene Improvement Intervention (BEHAVIORAL), Ask Me 3 (BEHAVIORAL).
Who is sponsoring clinical trial NCT02131727?
This trial is sponsored by Kent State University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02131727 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02131727's enrollment target sits among peer trials
324 8th of 15 higher than 8 of 15 other Respiratory Tract Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Respiratory Tract Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses
RECRUITING · NA
-
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
RECRUITING · NA
-
An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.
RECRUITING · NA
-
Vitamin D3 Supplementation to Prevent Respiratory Tract Infections
COMPLETED · NA
-
Patient Portal Flu Vaccine Reminders (RCT 6)
COMPLETED · NA
-
Measuring the Influence of Kefir on Children's Stools on Antibiotics (MILK)
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04164173 · 324 participants · NA
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
- NCT04708054 · 324 participants · Phase 2
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
- NCT05261399 · 324 participants · Phase 3
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
- NCT05353322 · 324 participants · NA
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia